Chenthamarakshan Vasu to Ligands
This is a "connection" page, showing publications Chenthamarakshan Vasu has written about Ligands.
Connection Strength
0.535
-
Activation of T cell checkpoint pathways during ?-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes. Immunology. 2022 07; 166(3):341-356.
Score: 0.180
-
Centrosomal P4.1-associated protein (CPAP) positively regulates endocytic vesicular transport and lysosome targeting of EGFR. Sci Rep. 2021 06 16; 11(1):12689.
Score: 0.169
-
Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance. Sci Rep. 2019 08 19; 9(1):12065.
Score: 0.149
-
OX40L/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells. J Immunol. 2013 Jun 01; 190(11):5516-25.
Score: 0.024
-
Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol. 2003 Feb 15; 170(4):2195-204.
Score: 0.012